Advertisement


Changchuan Jiang, MD, MPH, on Transportation Barriers, Delays in Cancer Care, and Increased Mortality for Patients With Cancer

2022 ASCO Quality Care Symposium

Advertisement

Changchuan Jiang, MD, MPH, of Roswell Park Comprehensive Cancer Center, discusses the lack of transportation as a potentially modifiable barrier to care for patients with cancer. Timely intervention may reduce visits to hospital emergency departments, lower costs, and improve outcomes (Abstract 70).



Transcript

Disclaimer: This video transcript has not been proofread or edited and may contain errors.
We know that cancer survivor are a very unique population, where is going very rapidly, over the past few years, due to the aging trend and advancing cancer treatment. On the same time, this is a really a vulnerable group with increased medical needs, more comorbidities, and increased health service use. Notably, our previous studies suggest that cancer survivor experience more difficulty with transportations, compared to adults without a cancer history. In this study, we really look at the cancer survivor and their transportation barrier and how these barriers impact their clinical outcomes. For example, we focus on their transportation barrier as the patient self-report delay in care, due to lack of transportation, and we also look at if they have a routine place for care and if they visit emergency room over the past 12 months. And we also look at their overall survival and cause-specific mortality, including cancer-specific mortalities. We find that cancer survivors experience a way higher risk of visiting emergency room and the lack of routine place for care when they experiencing difficulty with transportation. At same times, this vulnerable group of patients, once facing the transportation barrier, experience the highest risk of dying from any disease, and cancer, specifically. Our studies suggest it's very important to pay attention to the transportation, a issue that faced by patient and physician every single day. And really look at this and ask our patients, "Are you experiencing any difficulty getting to the clinic?" We don't want them to stay at home just because they don't have transportation. Then this problem will get larger, and they will experience worse outcome after that. We believe it's very important for us to screen, identify, and mitigate these barriers, and it will potentially improve the patients' outcome, reduce the health service use, and potentially save cost.

Related Videos

Issues in Oncology

Jensa C. Morris, MD: Oncology Hospitalist Co-Management May Be Linked to Efficient, High-Quality Care and Education

Jensa C. Morris, MD, of the Yale School of Medicine, Smilow Hospitalist Service, discusses her findings on the benefits of hospitalist co-management of patients with cancer: It reduced the length of hospital stay by 1 day, increased early discharge (before 11:00 AM) by threefold; raised the educational rankings of house staff, and lowered oncologists’ stress level, improving their ability to manage competing responsibilities (Abstract 1).

Symptom Management
Issues in Oncology

Dawn L. Hershman, MD, on Prophylactic Colony Stimulating Factors for Neutropenia: Improving Clinicians’ Prescribing Practices

Dawn L. Hershman, MD, of Columbia University College of Physicians and Surgeons, discusses findings that showed substantial variability in clinicians’ adherence to prescribing primary prophylactic colony stimulating factors in a pragmatic trial. Although the ability to opt out of the intervention is a feature of pragmatic trials, careful prestudy planning to estimate nonadherence is critical to ensure adequate power to detect an effect. Understanding reasons for intervention opt-outs may also inform future pragmatic studies aimed at improving adherence to practice guidelines.

Breast Cancer
Issues in Oncology

Regina Barragán-Carrillo, MD, on Breast Cancer Screening in the Transgender Population

Regina Barragán-Carrillo, MD, of Mexico’s National Institute of Medical Sciences and Nutrition Salvador Zubirán, discusses her findings showing that currently, physicians have limited knowledge about breast cancer screening in transgender patients. Were this topic addressed with widespread information, it could possibly reduce the health-care inequalities faced by this diverse group of patients (Abstract 71).

Palliative Care
Legislation

Xuesong Han, PhD, on Medicaid Expansion and Receipt of Palliative Care Among Individuals Newly Diagnosed With Advanced-Stage Cancers

Xuesong Han, PhD, of the American Cancer Society, discusses findings showing that among newly diagnosed patients with stage IV cancers, Medicaid expansion was associated with increases in receipt of palliative care, although overall usage was low. The increase varied by cancer type. Improving Medicaid coverage may facilitate access to guideline-based palliative care (Abstract 73).

Leukemia

Christopher E. Jensen, MD, on Older Adults With AML: A Price Paid for High-Intensity Chemotherapy?

Christopher E. Jensen, MD, of the University of North Carolina School of Medicine, talks about older adults with acute myeloid leukemia who receive high-intensity chemotherapy. Although they may live longer, much of their survival gains may be spent engaged in oncology care (Abstract 376).

Advertisement

Advertisement




Advertisement